Literature DB >> 8568536

Clonidine in the treatment of spasticity in patients with multiple sclerosis.

O A Khan, M J Olek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8568536     DOI: 10.1007/bf00866925

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  7 in total

1.  Clonidine in spinal cord injury.

Authors:  P W Nance; A H Shears; D M Nance
Journal:  Can Med Assoc J       Date:  1985-07-01       Impact factor: 8.262

2.  Reflex changes induced by clonidine in spinal cord injured patients.

Authors:  P W Nance; A H Shears; D M Nance
Journal:  Paraplegia       Date:  1989-08

3.  Reversal potential for noradrenaline-induced hyperpolarization of spinal motoneurons.

Authors:  K C Marshall; I Engberg
Journal:  Science       Date:  1979-07-27       Impact factor: 47.728

4.  Clonidine effect on spasticity: a clinical trial.

Authors:  W H Donovan; R E Carter; C D Rossi; M A Wilkerson
Journal:  Arch Phys Med Rehabil       Date:  1988-03       Impact factor: 3.966

5.  Early clinical experience with clonidine in spinal spasticity.

Authors:  F M Maynard
Journal:  Paraplegia       Date:  1986-06

6.  Clonidine in the treatment of brainstem spasticity. Case report.

Authors:  P R Sandford; S E Spengler; K B Sawasky
Journal:  Am J Phys Med Rehabil       Date:  1992-10       Impact factor: 2.159

7.  Clonidine transdermal system for treatment of spasticity in spinal cord injury.

Authors:  S I Weingarden; J G Belen
Journal:  Arch Phys Med Rehabil       Date:  1992-09       Impact factor: 3.966

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.